Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026)
Arcus Biosciences' Net Equity Issued and Repurchased came in at $16 million for Q2 2026, up 433.3% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Net Equity Issued and Repurchased of $306 million, up 115.5% year-over-year; for FY2025, it was $429 million, up 88.2% from FY2024.
- Net Equity Issued and Repurchased has increased in each of the last three years, though with a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $228 million in FY2024 (+812.0%), $25 million in FY2023 (+8.7%), $23 million in FY2022 (-89.5%) and $220 million in FY2021 (-49.3%).
- The five-year range for quarterly Net Equity Issued and Repurchased is -$235,000 (Q4 2021) to $279 million (Q4 2025).
- Business Quant data shows RCUS's Net Equity Issued and Repurchased at $3 million (Q1 2026), $279 million (Q4 2025) and $8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 16.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 279.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 142.00 Mn |
| Mar 31, 2024 | 228.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 19.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | -235,000.00 |
| Mar 31, 2021 | 220.24 Mn |
| Dec 31, 2020 | 224,000.00 |
| Mar 31, 2020 | 643,000.00 |
| Dec 31, 2019 | 520,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 695,000.00 |
API Access
Arcus Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();